Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity
This chemistry paper (2022) simulates the docking of 75 million molecules (tetrahydropyridines, THP) on the serotonin 2a (5-HT2a) receptor. The initial screening led to 17 molecules that were further refined down to two molecules ((R)-69 & (R)-70). These two had antidepressant effects (in mice) but didn't show (acute) psychoactive activity (head-twitch response, change in movement).
Authors
- John McCorvy
- Bryan Roth
- Kuglae Kim
Published
Abstract
There is considerable interest in screening ultralarge chemical libraries for ligand discovery, both empirically and computationally. Efforts have focused on readily synthesizable molecules, inevitably leaving many chemotypes unexplored. Here we investigate structure-based docking of a bespoke virtual library of tetrahydropyridines-a scaffold that is poorly sampled by a general billion-molecule virtual library but is well suited to many aminergic G-protein-coupled receptors. Using three inputs, each with diverse available derivatives, a one pot C-H alkenylation, electrocyclization and reduction provides the tetrahydropyridine core with up to six sites of derivatization. Docking a virtual library of 75 million tetrahydropyridines against a model of the serotonin 5-HT2A receptor (5-HT2AR) led to the synthesis and testing of 17 initial molecules. Four of these molecules had low-micromolar activities against either the 5-HT2A or the 5-HT2B receptors. Structure-based optimization led to the 5-HT2AR agonists (R)-69 and (R)-70, with half-maximal effective concentration values of 41 nM and 110 nM, respectively, and unusual signalling kinetics that differ from psychedelic 5-HT2AR agonists. Cryo-electron microscopy structural analysis confirmed the predicted binding mode to 5-HT2AR. The favourable physical properties of these new agonists conferred high brain permeability, enabling mouse behavioural assays. Notably, neither had psychedelic activity, in contrast to classic 5-HT2AR agonists, whereas both had potent antidepressant activity in mouse models and had the same efficacy as antidepressants such as fluoxetine at as low as 1/40th of the dose. Prospects for using bespoke virtual libraries to sample pharmacologically relevant chemical space will be considered.
Research Summary of 'Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity'
Introduction
Earlier work has shown that ultralarge virtual and DNA-encoded libraries can expand the chemical space sampled in ligand discovery, but many chemotypes remain absent or under-represented in these general-purpose sets. Kaplan and colleagues note that six-membered nitrogen heterocycles such as piperidines and pyridines are common in approved drugs, whereas tetrahydropyridines (THPs) — midway in saturation between pyridines and piperidines — are comparatively rare in make-on-demand libraries despite possessing desirable features (basic nitrogen, three-dimensionality and multiple sites for substitution). The authors developed convergent synthetic routes that give THP cores with up to six points of derivatisation, enabling the construction of a bespoke virtual library around this scaffold. This study set out to test whether a focused, synthetically tractable virtual library of THPs could be efficiently docked to identify new aminergic GPCR ligands, using the serotonin 5-HT2A receptor (5-HT2A R) as a therapeutically relevant test case. The aims were to (1) build and screen an ultralarge bespoke THP library by structure-based docking, (2) synthesise and optimise docking-prioritised hits, (3) determine receptor binding modes structurally, and (4) evaluate pharmacology and in vivo behavioural effects, with a particular interest in agonists that might retain antidepressant activity without classical psychedelic effects.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Topics
- Authors
- APA Citation
Kaplan, A. L., Confair, D. N., Kim, K., Barros-Álvarez, X., Rodriguiz, R. M., Yang, Y., Kweon, O. S., Che, T., McCorvy, J. D., Kamber, D. N., Phelan, J. P., Martins, L. C., Pogorelov, V. M., DiBerto, J. F., Slocum, S. T., Huang, X., Kumar, J. M., Robertson, M. J., Panova, O., . . . Ellman, J. A. (2022). Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity. Nature, 610(7932), 582-591. https://doi.org/10.1038/s41586-022-05258-z
References (10)
Papers cited by this study that are also in Blossom
Carhart-Harris, R. L., Giribaldi, B., Watts, R. et al. · New England Journal of Medicine (2021)
Wacker, D., Wang, S., Mccorvy, J. D. et al. · Cell (2017)
Ray, T. S. · PLOS ONE (2010)
Cao, D., Yu, J., Wang, H. et al. · Science (2022)
Nutt, D. J., Erritzoe, D., Carhart-Harris, R. L. · Cell (2020)
Kirchner, K. · Journal of Psychopharmacology (2014)
Goldberg, S. B., Pace, B. T., Nicholas, C. R. et al. · Psychiatry Research (2020)
Grob, C. S., Danforth, A. L., Chopra, G. S. et al. · JAMA Psychiatry (2011)
Ross, S., Bossis, A. P., Guss, J. et al. · Journal of Psychopharmacology (2016)
Shao, L-X,, Liao, C., Gregg, I. et al. · Neuron (2021)
Cited By (16)
Papers in Blossom that reference this study
Agrawal, R., Gillie, D., Mungenast, A. et al. · ACS Chemical Neuroscience (2025)
Jain, M. K., Gumpper, R. H., Slocum, S. T. et al. · Neuron (2025)
Shao, L-X,, Tan, D., Liao, C., Davoudian, P. A. et al. · Nature Communications (2025)
Gumpper, R. H., Jain, M. K., Kim, K. et al. · Nature Communications (2025)
Rucker, J., Butler, M., Hambleton, S. et al. · Headache (2024)
Lyu, J., Kapolka, N., Gumpper, R. et al. · Science (2024)
De Filippo, R., Schmitz, D. · Neuroscience and Biobehavioral Reviews (2024)
Madsen, M. K., Petersen, A. S., Stenbæk, D. S. et al. · Headache (2024)
Cameron, L. P., Benetatos, J., Lewis, V. et al. · Journal of Neuroscience (2023)
Jaster, A. M., González-Maeso, J. · Molecular Psychiatry (2023)
Show all 16 papersShow fewer
Wallach, J., Cao, A. B., Calkins, M. M. et al. · Biorxiv (2023)
Heifets, B. D., Olson, D. E. · Neuropsychopharmacology (2023)
Tiwari, P., Sayali, C., Doss, M. K. et al. · Psychedelic Medicine (2023)
Moliner, R., Girych, M., Brunello, C. A. et al. · Nature Neuroscience (2023)
Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. E. et al. · Neuropharmacology (2023)
Cameron, L. P., Patel, S. D., Vargas, M. V. et al. · ACS Chemical Neuroscience (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.